Cart summary

You have no items in your shopping cart.

RORγt inhibitor 4

SKU: orb2945049

Description

Compound 9a is a potent, orally bioavailable, and brain-penetrant RORγt inverse agonist. It demonstrates efficacy in Th17-driven disease models, including the amelioration of clinical symptoms in experimental autoimmune encephalomyelitis (EAE) in vivo.

Research Area

Metabolism Research

Images & Validation

Key Properties

CAS Number1426803-07-7
MW518.333
FormulaC22H16Cl2F3NO4S
SMILESO=C(NC=1C=C(Cl)C(=C(Cl)C1)C=2C=CC=CC2OC(F)(F)F)CC3=CC=C(C=C3)S(=O)(=O)C
TargetROR

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • 5J-4 [orb1305391]

    96.12% (May vary between batches)

    827001-82-1

    312.34

    C16H12N2O3S

    5 mg, 10 mg, 25 mg, 50 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

RORγt inhibitor 4 (orb2945049)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%